Cost-Effectiveness Analysis of Long-acting Injectable Once-monthly of Aripiprazole Compared with Long-acting Injectable Once-monthly Paliperidone Palmitate for the Treatment of Stable Schizophrenia Patients in Thailand

Objective: Long-acting injectable (LAI)-aripiprazole and LAI-paliperidone palmitate are both second-generation antipsychotics that have been introduced to increase drug compliance in patients. These attributes are expected to enhance drug compliance, particularly in stable patients. The previous st...

Descripció completa

Dades bibliogràfiques

Autors principals:	Piyanut Ueapanjasin, Wiwat Thavornwattanayong, Jadesada Lertsirimunkong, Kamolpat Chaiyakittisopon
Format:	Artigo
Idioma:	Inglês
Publicat:	Faculty of Medicine Siriraj Hospital 2023-10-01
Col·lecció:	Siriraj Medical Journal
Matèries:	Aripiprazole cost-effectiveness long-acting injectable antipsychotics paliperidone stable schizophrenia patients
Accés en línia:	https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/264770
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!